Trials / Active Not Recruiting
Active Not RecruitingNCT05730647
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Consorzio Oncotech · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This will be a prospective, multicenter, observational study. The primary objective is to record the choice, in clinical practice, of adjuvant hormone therapy (tamoxifen, tamoxifen + LhRh, aromatase inhibitors + LhRh) in premenopausal patients with estrogen-receptor positive breast cancer. The secondary objective is to correlate adjuvant hormone therapy choices with biological characteristics of the tumor (T size, lymph node status, grade, receptor level, Ki67, HER2 status) and patient characteristics (age, prior chemotherapy treatment).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None intervention (observational study) | None intervention (observational study) |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2022-08-01
- Completion
- 2032-07-31
- First posted
- 2023-02-16
- Last updated
- 2023-02-16
Locations
40 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT05730647. Inclusion in this directory is not an endorsement.